Another Trial of Ancrod for Acute Ischemic Stroke

Ancrod, a substance with antithrombotic properties, is derived from the venom of the Malayan pit viper. In the previously published, manufacturer-funded, randomized Stroke Treatment with Ancrod Trial (STAT), patients from North America with acute ischemic stroke had significantly better functional status at 3 months with ancrod than with placebo — each initially administered within 3 hours after symptom onset (Journal Watch Neurology Aug …